Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

6.4K
A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.4K
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Volatile Anesthetic Intensive Care Unit Sedation: Comment.

Anesthesiology·2025
Same author

Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.

BMC anesthesiology·2022
Same author

Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility.

Human molecular genetics·2022
Same author

Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

Episodic RYR1-Related Crisis: Part of the Evolving Spectrum of RYR1-Related Myopathies and Malignant Hyperthermia-Like Illnesses.

A&A practice·2021
Same author

Drug-induced Hyperthermic Syndromes in Psychiatry.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2021
Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026
Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026
Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026
Same journal

What Is Low Back Pain?

JAMA·2026
Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
07:56

Protocol for Long Duration Whole Body Hyperthermia in Mice

Published on: August 25, 2012

12.0K

Malignant hyperthermia: update on susceptibility testing.

Ronald S Litman1, Henry Rosenberg

  • 1Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. Litmanr@email.chop.edu

JAMA
|June 16, 2005
PubMed
Summary
This summary is machine-generated.

Malignant hyperthermia (MH) is a genetic disorder causing a hypermetabolic crisis upon exposure to anesthetic agents. Identifying mutations in the ryanodine receptor gene (RYR1) offers a new diagnostic approach for MH susceptibility.

More Related Videos

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.7K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.9K

Related Experiment Videos

Last Updated: May 2, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
07:56

Protocol for Long Duration Whole Body Hyperthermia in Mice

Published on: August 25, 2012

12.0K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.7K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.9K

Area of Science:

  • Anesthesiology
  • Genetics
  • Pharmacology

Background:

  • Malignant hyperthermia (MH) is a pharmacogenetic disorder causing a hypermetabolic crisis.
  • Clinical manifestations include muscle rigidity, acidosis, tachycardia, and hyperthermia.
  • The condition results from abnormal calcium release from the sarcoplasmic reticulum, often due to inherited mutations in the ryanodine receptor gene (RYR1).

Purpose of the Study:

  • To investigate the role of ryanodine receptor (RYR1) gene mutations in malignant hyperthermia (MH) susceptibility.
  • To explore mutation analysis as a diagnostic tool for MH.

Main Methods:

  • Review of existing research on malignant hyperthermia (MH) and ryanodine receptor (RYR1) gene mutations.
  • Discussion of the limitations of the current gold standard diagnostic test (caffeine-halothane contracture test).

Main Results:

  • Ryanodine receptor (RYR1) mutations are identified in at least 25% of MH-susceptible individuals in North America.
  • Mutation analysis of the RYR1 gene has become available in the United States.

Conclusions:

  • RYR1 gene mutation analysis is emerging as a valuable tool for diagnosing malignant hyperthermia (MH) susceptibility.
  • Genetic testing offers a promising alternative or adjunct to invasive diagnostic methods.